ReviewAdvanced materials (Deerfield Beach, Fla.)2026
Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications.
Review in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Living inorganic nanomaterials are defined as inorganic nanostructures that are integrated with living bacteria, cells, or biologically active cell-derived components. This unique integration addresses key limitations of traditional inorganic nanomaterials in biomedical applications, including poor biocompatibility and limited ability to cross physiological barriers. This review outlines the developmental trajectory of bioactive inorganic nanomaterials, focusing on their evolution from passive carriers to life-integrated therapeutic platforms. From biomacromolecule-conjugated nanoparticles to nanozymes, culminating in living inorganic nanomaterials, we highlight the design of living cell- and bacteria-conjugated inorganic nanomaterials for drug delivery, diagnosis, and therapy. We discuss the clinical translation and artificial intelligence-aided design of bioactive inorganic nanomaterials. We also discuss the translational challenges and opportunities of living inorganic nanomaterials as a new generation of intelligent biomedical tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.